Immunoprophylaxis of experimental Mycoplasma bovis arthritis in calves. Protective efficacy of live organisms and formalinized vaccines

Live Mycoplasma bovis (M. bovis) organisms given subcutaneously or intraperitoneally protected nine of ten calves and eight of nine calves, respectively, from clinical arthritis, while the formalinized vaccine given subcutaneously protected eight of ten calves. In contrast, clinical arthritis was induced in all non-vaccinated calves that were challenged intravenously. The arthritic lesion was more severe in non-vaccinated calves than in the few vaccinated calves that developed clinical arthritis. Unlike formalinized vaccine, live M. bovis culture given subcutaneously provoked a local reaction at the site of injection in most calves in the form of oedematous plaques of about 7–8 cm in diameter. Results suggest that the formalinized vaccine may offer a practical approach to the control of Mycoplasma bovis arthritis in calves.     

In vitro DNA synthesis in lymphocytes from turkeys vaccinated with LaSota, TC, and inactivated Newcastle disease vaccines.

In vitro cultures of peripheral blood lymphocytes from turkeys vaccinated and revaccinated with Newcastle disease (ND) vaccines were stimulated to transformation when exposed to the homologous and heterologous strains of ND virus. The mitogenesis was measured by the uptake of 3H-thymidine into newly synthesized DNA. There was considerable difference in DNA synthesis by lymphocytes drawn 0, 2, 5, and 10 days after vaccination and revaccination with the three vaccines. Stimulation of DNA synthesis, evident as early as the 2nd day, was highest in lymphocytes from turkeys vaccinated or revaccinated with TCND intramuscularly. Stimulation was least in lymphocytes from turkeys vaccinated and revaccinated with LaSota vaccine by aersol. Stimulation was intermediate from an inactivated vaccine given subcutaneously. DNA synthesis was greater with the homologous than with the heterologous strains of NDV. Synthesis was even greater when the same strain was used as a viral suspension in allantoic or cell-culture fluid than the commercial vaccine. The bovine paramyxovirus (PI3) resulted in a minimum DNA synthesis or completely inhibited it. A many-fold (order of magnitude) stimulatory effect was observed when PHA was used as an antigen. The stimulation of DNA synthesis did not parallel the HI antibody response.     

Specificity of the enzyme-linked immunosorbent assay (ELISA) for antibodies in the sera of specific pathogen-free lambs vaccinated with Pasteurella haemolytica antigens

Pooled serum from specific pathogen-free (SPF) lambs vaccinated with sodium salicylate extracted (SSE) antigens of Pasteurella haemolytica serotype A1 was shown to contain antibody to other A serotype SSE antigens when tested by the enzyme-linked immunosorbent assay (ELISA). Specific antibody to serotype A1 SSE antigens was demonstrated by absorption of the serum pool with heterologous serotype SSE antigens.The type-specific antigens of serotypes A1 and A9 were prepared by phenol—water extraction (PWE) of their respective SSE antigens. The PWE antigens were examined in a sandwich ELISA where rabbit IgG anti-P. haemolytica A1 cells or A9 cells was used as a coating layer to bind PWE antigens. The specificity of these antigens was demonstrated by marked reduction of reactivity between serum from SPF lambs vaccinated with SSE of serotypes A1 or A9.     

Antibody responses in ostriches (Struthio camelus) vaccinated with commercial live and killed Newcastle disease vaccines

Three ostriches (Struthio camelus) were immunized with commercially available live and killed Newcastle disease (ND) vaccines for chickens and the antibody responses to the ND vaccines were evaluated by a virus-neutralization (VN) test. Primary vaccination with the live vaccine, B1, by eye drop was followed with two shots of alum-precipitated killed vaccine via subcutaneous injection in the neck. As a final booster, another live vaccine, Clone 30, was used by eye drop. A VN antibody titer, more than 1:10 was observed for 6 months. This is the first report on the use of a live vaccine by eye drop as a booster in ostriches as well as evaluating responses to ND vaccines using the VN test in this avian species.     

Infection of specific-pathogen-free lambs with parainfluenza virus type 3, Pasteurella haemolytica and Mycoplasma ovipneumoniae

Groups of specific-pathogen-free lambs were inoculated with combinations of parainfluenza virus type 3 (PI₃), Pasteurella haemolytica (P.h.) and Mycoplasma ovipneumoniae ( (M.o.). Acute, necrotising bronchopneumonia developed in 8/9 lambs inoculated with PI₃ followed by P.h. whereas only 1/5 lambs inoculated with PI₃ followed by a combination of M.o. and P.h. developed a pneumonic lesion. When M.o. was inoculated 29 days before PI₃ and P.h., pneumonia developed in 3/4 lambs but M.o. was not reisolated from any of the lungs. Pneumonia was observed in 1/5 lambs inoculated with P.h. alone and in 1/5 inoculated with M.o. plus P.h. In addition, one lamb in the latter group died of acute septicaemic pasteurellosis. None of the lambs inoculated with M.o. alone, PI₃ alone or PI₃ followed by M.o. had any gross or microscopic evidence of pneumonia although the virus alone, or in combination, did produce minor pulmonary lesions.These data suggest that M.o. is not an important primary or secondary lung pathogen.     

Cytotoxic effect of Pasteurella haemolytica on ovine bronchoalveolar macrophages in vitro

Live Pasteurella haemolytica A1 was shown to have a cytotoxic effect on suspensions of sheep bronchoalveolar macrophages. Cytotoxic activity was also demonstrable in bacteria-free supernatants from suspensions containing P. haemolytica. Heat-killed and ultraviolet killed organisms of P. haemolytica and live Staphylococcus aureus were not toxic to sheep BAM. These results suggest that a bacterial cell-free cytotoxin is produced by metabolically active P. haemolytica. Guinea-pig peritoneal macrophages, McCoy and pig kidney epithelial cell suspensions were unaffected by live P. haemolytica and supernatant from P. haemolytica cultures, indicating that the cytotoxin may only affect phagocytic cells of ovine or bovine origin.     

不同的血清学方法对布病疫苗免疫绵羊抗体检测结果的比较研究

将国内广泛用于预防羊布病的S2和M5疫苗免疫绵羊,然后定期采血进行细菌分离和血清学检测,并比较血清学方法的检测结果。结果表明ELISA操作方便,具有较好的敏感性和特异性,建议在检疫中用敏感性较高的RBT初筛,用特异性较好的ELISA确诊,以得到较好的效果。     

The pathogenesis of sequential infection with parainfluenza virus type 3 and Pasteurella haemolytica in sheep

Conventionally-delivered colostrum-deprived lambs were inoculated with either parainfluenza virus type 3 (PI₃) alone or PI₃ followed, 6 days later, by Pasteurella haemolytica (P.h.). Six out of 20 lambs died or were killed in extremis within 3 days of the inoculation of P.h.; the remainder were selected at random and killed from 1 to 28 days after the inoculation of P.h.Extensive pneumonic lesions developed in a large proportion of lambs inoculated with both agents but in none of those inoculated with the virus alone. Histologically, the pneumonic lesions fell into two categories: necrotic lesions, demarcated by a zone of either oat-cell or neutrophil infiltration, and a milder, purulent bronchopneumonia. Bacterial numbers tended to be higher in necrotic lesions than they were in purulent lesions. Virus titres in nasal secretions, on the day of inoculation of P.h. (day 6), also were higher in animals that developed necrotic lesions than they were in those that developed milder lesions. Nevertheless, titres were similar in both groups on day 4.Necrotic lesions persisted for at least 21 days as residual encapsulated abscesses which still contained viable P.h. whereas the milder, purulent bronchopneumonia was not detected later than 3 days after the inoculation of P.h..     

Exploitation of intestinal colonization-inhibition between salmonella organisms for live vaccines in poultry: potential and limitations

Immunization represents one of the most important methods to increase the resistance of chickens against Salmonella infection. In addition to the development of an adaptive immune response, oral administration of live Salmonella strains to day-old chicks provides protection against infection within hours by intestinal colonization-inhibition. For the exploitation of this phenomenon, practical information on colonization-inhibition between Salmonella organisms is needed. Colonization-inhibition capacity between Salmonella strains from serogroups B, C1, C2, D and G was assessed in chickens. The most profound level of intestinal colonization-inhibition occurred between isogenic strains. Inhibition between strains of the same serovar was greater than that between strains of different serovars. The degree of inhibition between different serovars was not sufficiently high to identify a single strain which might inhibit a wide range of other Salmonella organisms. However, as Salmonella Enteritidis is the dominant serovar in poultry in many countries and because of the profound colonization-inhibition within this serovar there is a considerable potential to exploit this phenomenon in the development of novel live S. Enteritidis vaccines. Treatment of young chicks with mixtures of different Salmonella serovars resulted not only in a very strong growth inhibition of the isogenic strains but also in a substantial inhibition of heterologous serovars. The potential of mixtures of heterologous Salmonella strains as a 'Salmonella Inhibition Culture' and as a 'live Salmonella vaccine' should be further explored.     

Studies on the efficacy of different adjuvants in live stock specific bacterial vaccines for turkeys against Bordetella infection and onset of antibody titers in respect to the age of the turkey poults

For evaluating the influence of the age of the vaccinated birds on the development of antibodies, five groups of turkey poults were inoculated subcutaneously at day 1, 7, 10, 14 and 21 of life with vaccine containing inactivated Bordetella avium and Freund's incomplete adjuvant. No matter which vaccine schedule was used, serum antibodies with the ELISA were first detected at the 28th day of life and increased continuously until the 49th day, when it exhibited either a peak or a plateau. Aluminium hydroxide, Freund's complete and incomplete adjuvant and a mineral oil-arlacel-tween-mixture being permitted adjuvants (appendix II EWG 2377/90) and the adjuvant Gerbu 100 were evaluated for their suitability. Turkeys were vaccinated at the age of three weeks and examined clinically as well as serologically up to the 11th week. Humoral antibodies were detected quantitatively using an ELISA for IgG and a microagglutination test for IgM and qualitatively using immunodiffusion. The damage at the application site was rated by measurement of the swelling of the tissue. In the 10th week, the animals were infected with the agent for challenge. The serological examination for IgG antibodies in the ELISA both treatments with Freund's adjuvants resulted in high titers, which differed significantly from the unvaccinated control after 21 days. IgM could be detected from day 7 onwards in all vaccinated groups and showed the highest titers when aluminium hydroxide was used as adjuvant. In the immunodiffusion assay, precipitating antibodies could be found from the first week after vaccination onwards. There was no correlation between the occurrence of precipitating antibodies and ELISA titers. The measurements of the swelling of the tissue in the beginning showed the largest swellings in the animals injected with Freund's incomplete adjuvant and differed significantly from the unvaccinated control. In the 10th week, the animals were infected with Bordetella avium for challenge. In comparison to the unvaccinated animals, all vaccinated turkeys, no matter which adjuvant was used, showed a distinct and significant reduction of the reisolation rate.     

Effect of ammonia on the quantitative clearance of Escherichia coli from lungs, air sacs, and livers of turkeys aerosol vaccinated against Escherichia coli

Turkeys were given an aerosol vaccine to determine their ability to clear a virulent inhaled pathogenic strain of Escherichia coli, while they were being maintained in the presence of atmospheric NH3. Turkeys were exposed to 2 concentrations of NH3 (10 and 40 microliters/L of air). More E coli was found in lungs, air sacs, and livers of turkeys exposed to NH3. Turkeys not exposed to NH3 had better clearance of E coli. Vaccination against E coli improved the rate of clearance of E coli in birds not exposed to NH3.     

Effects of bursectomy, irradiation, and cyclophosphamide on turkeys vaccinated with CU cholera strain

Turkeys surgically bursectomized, irradiated, and/or injected with cyclophosphamide at 1 day were vaccinated with the live Clemson University (CU) strain of Pasteurella multocida. Bursectomized turkeys vaccinated via drinking water or wing-web puncture at 7 weeks and challenged at 11 weeks had a significantly (P less than 0.05) lower survival rate after challenge than unbursectomized controls. Bursectomized and unbursectomized turkeys vaccinated via drinking water at 7 weeks, revaccinated via the auditory tube at 11 weeks, and challenged at 15 weeks had similar survival rates. The vaccinated bursectomized turkeys had significantly (P less than 0.05) lower levels of serum anti-P. multocida antibody than vaccinated unbursectomized controls. Radiation had no immunosuppressive effect. The immunosuppressive effect of cyclophosphamide was dosage-dependent. Bursectomy and injection of cyclophosphamide in the same turkey were complementary. It was concluded that in young turkeys, the development of immunity to the avirulent CU vaccine is highly dependent upon the bursa of Fabricius, but that as they grow older the bursa is of less importance, particularly if they were vaccinated via a parenteral route, such as in the air spaces of the head.     

Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines.

Chickens and turkeys vaccinated with inactivated virus oil-emulsion vaccines containing different concentrations of either 1 (monovalent) or 4 (polyvalent) strains of avian influenza virus (AIV) were challenged-exposed with virulent AIV A/chicken/Scotland/59 or A/turkey/Ontario/7732/66. Four of 6 vaccines protected completely against postexposure mortality. Vaccine valency did not alter the serologic and challenge-exposure responses of chickens vaccinated with AIV A/turkey/Wisconsin/68, which was the virus component common to both monovalent and polyvalent vaccines. The magnitude of the serologic responses and protection against challenge-exposure were dependent on the concentration of virus in the vaccines. These data indicate that control of virulent AIV in chickens and turkeys by vaccination with inactivated vaccines may be feasible.     

Studies of parvovirus vaccination in the dog: the performance of live attenuated feline parvovirus vaccines

The performance of three live attenuated feline parvovirus vaccines licensed for use in the dog was studied. At the end of the primary vaccination course 67 per cent of dogs had inadequate antibody levels (less than or equal to 32) as measured by a haemagglutination inhibition test. Interference by maternal antibody accounted for some of the failures but the fact that there was no significant difference in performance between dogs vaccinated at 12 weeks or 16 weeks of age indicated that maternal antibody was not the only factor.     

兽用疫苗中霉形体污染的套式PCR检测技术建立及初步应用

根据GenBank公布的鸡毒霉形体、猪肺炎霉形体、猪滑液霉形体和絮状霉形体的16s rRNA基因序列,利用引物设计软件DNAStar和Primer5.0自行设计3对特异性引物,以市场上常见的兽用疫苗为检测对象进行试验,优化反应体系,建立了兽用疫苗霉形体污染检测的套式PCR方法。同时,本试验还对市场上的兽用疫苗进行随机抽查检测,其检出率分别为24.2%(23/95)、21.1%(20/95)和14.7%(14/95)。